C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
06/2011
06/23/2011	US20110150921 Novel fusion proteins and use thereof for preparing hepatitis c vaccines
06/23/2011	US20110150920 Allergy Vaccines Containing Hybrid Polypeptides
06/23/2011	US20110150919 Compositions and methods for the therapy and diagnosis of breast cancer
06/23/2011	US20110150915 Polyvalent vaccine
06/23/2011	US20110150914 Compositions and methods for dengue virus (dv) treatment and vaccination
06/23/2011	US20110150911 Methods and reagents for treating, preventing and diagnosing bunyavirus infection
06/23/2011	US20110150910 Methods of inducing an immune response
06/23/2011	US20110150903 Fgf-r4 receptor-specific antagonists
06/23/2011	US20110150901 Binding proteins that bind to human fgfr1c, human beta-klotho and both human fgfr1c and human beta-klotho
06/23/2011	US20110150892 Human antibodies that bind lymphocyte activation gene-3 (lag-3) and uses thereof
06/23/2011	US20110150889 Haemophilus influenzae type iv pili
06/23/2011	US20110150888 Anti-hepcidin antibodies and methods of use
06/23/2011	US20110150887 Methods and products relating to gsk3beta regulation
06/23/2011	US20110150886 Anti-areg/hb-egf antibodies and treatment
06/23/2011	US20110150885 Aminoacyl trna synthetases for modulating hematopoiesis
06/23/2011	US20110150883 Compositions and methods for the therapy and diagnosis of breast cancer
06/23/2011	US20110150882 Compositions and methods for the therapy and diagnosis of ovarian cancer
06/23/2011	US20110150874 Fusion proteins, uses thereof and processes for producing same
06/23/2011	US20110150868 Diagnostic and therapeutic methods and compositions involving pten and breast cancer
06/23/2011	US20110150865 Antibodies to lymphotoxin-alpha
06/23/2011	US20110150863 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
06/23/2011	US20110150860 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
06/23/2011	US20110150852 Novel Strain of Lactobacillus Paracasei Subspecies Paracasei Having Antimicrobial and Immunomodulatory Properties
06/23/2011	US20110150849 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules
06/23/2011	US20110150841 Secretion System and Methods for its Use
06/23/2011	US20110150840 Detection and Treatment of Glyco-Enzyme-Related Disease
06/23/2011	US20110150828 Interleukin-2/soluble tgf-beta type ii receptor b conjugates and methods and uses thereof
06/23/2011	US20110150774 Screening for modulators of ces1 and/or ces3 for the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
06/23/2011	US20110150773 Modulators of acetyl-coenzyme a acyltransferase 1 or 2 in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
06/23/2011	US20110150771 Chimeric west nile/dengue viruses
06/23/2011	US20110150764 Stroke-tageting peptide and use thereof
06/23/2011	US20110150760 PRLR-Specific Antibody and Uses Thereof
06/23/2011	CA2783254A1 Endpoint taqman methods for determining zygosity of corn comprising tc1507 events
06/23/2011	CA2783005A1 Promoter for regulation of gene expression in plant roots
06/22/2011	EP2336370A2 Recombinant Newcastle disease virus RNA expression systems and vaccines
06/22/2011	EP2336359A1 1L1RL-1 as a cardiovascular disease marker and therapeutic target
06/22/2011	EP2336331A1 Novel proteases and variants thereof
06/22/2011	EP2336320A1 Sensizitation of cancer cells to therapy using sina targeting genes from the 1p and 19q chromosomal regions
06/22/2011	EP2336319A1 Antisense modulation of apolipoprotein B expression
06/22/2011	EP2336318A1 Antisense modulation of apolipoprotein B expression
06/22/2011	EP2336302A1 Nucleotide sequence encoding the enzyme I-sceI and the uses thereof
06/22/2011	EP2336145A1 Antisense modulation of apolipoprotein B expression
06/22/2011	EP2335501A1 Phytase-containing animal food and method
06/22/2011	EP2334695A1 Therapeutic ribonucleases
06/22/2011	EP2334692A1 Rna monomers containing o-acetal levulinyl ester groups and their use in rna microarrays
06/22/2011	EP2334339A2 Diagnostic, prognostic and therapeutic uses of mirs in adaptive pathways and/or disease pathways
06/22/2011	EP1680507B1 Bacterial expression of protease inhibitors and variants thereof
06/22/2011	EP1619951B1 Methods and compositions for treating disorders
06/22/2011	EP1556402B1 In vivo gene silencing by chemically modified and stable sirna
06/22/2011	EP1412752B1 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids
06/22/2011	EP1328545B1 Human gene critical to fertility
06/22/2011	CN1912135B RNA affinity media and preparation method thereof
06/22/2011	CN101591651B Method for extracting microbial total DNA of cotton dreg fermentation sample
06/22/2011	CN101463048B Ruthenium complex inducing DNA conformation transition and preparation thereof
06/22/2011	CN101423541B Separation method of nucleic acid and glycosaminoglycan
06/21/2011	US7966338 Computer-directed assembly of a polynucleotide encoding a target polypeptide
06/21/2011	US7964770 Seed-preferred promoter from Sorghum kafirin gene
06/21/2011	US7964717 Rna sequence for therapy of cancer; control degradation and block transscription of messenger Rna that is translation product of target gene
06/21/2011	US7964716 Fluorescent primer system for detection of nucleic acids (Q priming)
06/21/2011	US7964715 Promoter sequences and the use thereof
06/21/2011	US7964714 Gene expression suppression agents
06/21/2011	US7964713 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics
06/21/2011	US7964711 Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same
06/21/2011	US7964710 EML4-ALK fusion gene
06/21/2011	US7964709 Mutant tyrosine repressor, a gene encoding the same, and a method for producing L-DOPA
06/21/2011	US7964579 Compositions and methods for topical delivery of oligonucleotides
06/21/2011	US7964578 Conjugates and compositions for cellular delivery
06/21/2011	US7964577 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
06/21/2011	US7964576 Anti-arthropod vector vaccines, methods of selecting and uses thereof
06/21/2011	US7964575 Use of a galectin-1-targeted RNAi-based approach for the treatment of cancer
06/21/2011	US7964572 High affinity nucleic acid ligands of complement system proteins
06/21/2011	US7964570 Administering a recombinant adeno-associated virus (rAAV) containing a transgene that encodes a protein MBNL1, MBNL2, or MBNL3
06/21/2011	US7964393 Constitutive promoter Lip3
06/21/2011	US7964382 DNA encoding a protein having D-lactate dehydrogenase activity and uses thereof
06/21/2011	US7964381 Variant form of urate oxidase and use thereof
06/21/2011	US7964375 Polynucleotides encoding human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
06/21/2011	US7964373 Transgenic cell models comprised of osmosensing histidine kinase for use in identifying fungicides; polynucleotide encoding the kinase; drug screening
06/21/2011	US7964357 Isolated genomic polynucleotide fragments from chromosome 12 that encode human mouse double minute 2 homolog
06/21/2011	US7964356 Method for generating aptamers with improved off-rates
06/21/2011	US7964355 Assays based on detection of photobleaching reaction products from dye catalytic complex
06/21/2011	US7964352 3′-OH unblocked nucleotides and nucleosides, base modified with labels and photocleavable, terminating groups and methods for their use in DNA sequencing
06/21/2011	US7964351 Using variation in human leukocyte antigen as evaluative tool in prediciting negative response to allopurinol drugs; prognosing toxic epidermal necrolysis and/or stevens-johnson syndrome
06/21/2011	US7964348 Polynucleotide primers for use in detecting transposon/insertion event in plant genome
06/21/2011	US7964345 Using probe visualization as tool in detecting chromosomal rearrangements in cells; colorimetic analysis; cancer diagnosis
06/21/2011	US7964344 Stable hybrid
06/21/2011	US7964343 Using column chromatography to isolate preferential polynucleotides from solution; electrospray mass spectrometry
06/21/2011	US7964342 Methods for analyzing methylated CpG islands and GC rich regions
06/21/2011	CA2505786C Methods for identifying risk of breast cancer and treatments thereof
06/21/2011	CA2497740C Multiplexed analysis of polymorphic loci by probe elongation-mediated detection
06/21/2011	CA2413316C Genetically modified plants with heterogeneous proteinase inhibitor sapin2a and methods of use thereof for the inhibition of endogenous trypsin-and chymotrypsin-like activities
06/21/2011	CA2386019C Methods related to immunostimulatory nucleic acid-induced interferon
06/21/2011	CA2250854C Methods for the diagnosis and prognosis of cancer
06/21/2011	CA2198966C Method for cleaving chimeric protein using processing enzyme
06/21/2011	CA2171336C Recombinant il4 antibodies useful in treatment of il4 mediated disorders
06/16/2011	WO2011072292A2 Phase changing formulations of rna and rna derivatives
06/16/2011	WO2011072082A2 Modulation of hsp47 expression
06/16/2011	WO2011071883A1 Anti-inflammatory antibodies and uses therefor
06/16/2011	WO2011071078A1 Aromatic compound, modification carrier that uses same and is used for synthesizing an oligonucleotide derivative, oligonucleotide derivative, and oligonucleotide construct
06/16/2011	WO2011069227A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof
06/16/2011	WO2011069200A1 Hyperprimers

1 ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 ... 899